Intellectual Property India Publishes Patent Application for 'Genetically Engineered Cells Having Anti-Nectin4 Chimeric Antigen Receptors, And Uses Thereof' Filed by Century Therapeutics, Inc.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053526 A) filed by Century Therapeutics, Inc., Philadelphia, on June 2, for 'genetically engineered cells having anti-nectin4 chimeric antigen receptors, and uses thereof.'

Inventor(s) include Borges, Luis; Carton, Jill, Marinari; Naso, Michael, Francis; Wallet, Mark; Wheeler, John; and Hall, Matthew, S.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "Provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing an anti-Nectin4 chimeric antigen receptor (CAR) and, optionally, an inhibito...